Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting
Go back to Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting| (NASDAQ: GRCL) | Delayed: 10.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.25 | 52 Week High | $ | |||
| Open | $10.25 | 52 Week Low | $ | |||
| Day High | $10.25 | P/E | N/A | |||
| Day Low | $10.25 | EPS | $ | |||
| Volume | 1,851 | |||||
